Skip to content

The effects of statins on skeletal muscle mitochondria:a pilot study?

The effects of statins on skeletal muscle mitochondria:a pilot study? - Statins and mitochondria

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON42199
Enrollment
30
Registered
2015-09-23
Start date
2015-11-11
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

skeletspier mitochondriale functie, algemene spierfunctie en fitheid the effects of statins on musle mitochondrial function the effects of statins on the aerobic energy metabolism

Interventions

symptomatic + asymptomatic statin users placebo intake for a period of 12 weeks in a singleblind fashion
mitochondrial energy metabolism
skeletal muscle

Sponsors

Integrative fysiologie
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: o Age: 18-70 years old o Current statin user: (group 1-2) for at least three months o Mentally able/ allowed to give informed consent

Exclusion criteria

Exclusion criteria: o familial hypercholesterolemia o history of a cardiovascular event within 1 year of study participatie o impaired liver function ( ALAT, ASAT, gamma-GT > 3x ULN) o known hereditary muscle defect; creatine kinase > 5x ULN known mitochondrial disorder o Medication known to potentially interfere with muscle metabolism (fibrates, Beta blockers, laxatives, diuretics, bronchodilatators) o Impaired kidney function: creatinin 100 umol/l o Diabetes mellitus o Engagement in exercise for more than two hours per week o contraindications for the exercise test (as explained in the protocol and the SOP) or muscle biopsy (see SOP)

Design outcomes

Primary

MeasureTime frame
The main study outcome paramters are: 1.the energy generating capacity of muscle mitochondria, 2. muscle function (muscle strength, muscle contraction efficiency,muscle fatigability), 3. maximal aerobic capacity These parameters shall be compared between the three study groups

Secondary

MeasureTime frame
1. Mitochondrial number (in muscle biopsy), 2. Blood paramters: Lipid profile (Total cholesterol, HDL-, LDL-cholesterol, triglycerides), liver enzymes (ASAT, ALAT, gamma-GT), creatine kinase, pyruvate, lactate 3. statin concentrations in muscle and blood 4. Questionnaires on muscle complaints (Short-form McGill pain questionnaire and Short-form Brief Pain Inventory)

Countries

The Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)